XML 18 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash Flows from Operating Activities    
Net income $ 99,967 $ 8,188
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 19,046 17,804
Stock option expense 7,305 6,055
Noncash long-term incentive compensation 2,942 1,783
Provision/(benefit) for deferred income taxes 2,173 (34,876)
Noncash directors' compensation 766 766
Amortization of restricted stock awards 446 638
Amortization of debt issuance costs 288 258
Litigation settlement   90,000
Provision for uncollectible accounts receivable   8,250
Changes in operating assets and liabilities:    
(Increase)/decrease in accounts receivable (6,057) 5,804
(Increase)/decrease in inventories (362) 137
Increase in prepaid expenses (113) (1,573)
Decrease in accounts payable and other current liabilities (14,909) (6,931)
Change in current income taxes 10,136 2,982
Increase in other assets (5,667) (4,152)
Increase in other liabilities 4,889 3,754
Other sources 186 1,437
Net cash provided by operating activities 121,036 100,324
Cash Flows from Investing Activities    
Capital expenditures (23,872) (28,133)
Business combinations (1,875) (525)
Other sources 533 87
Net cash used by investing activities (25,214) (28,571)
Cash Flows from Financing Activities    
Proceeds from revolving line of credit 358,350 135,800
Payments on revolving line of credit (281,150) (115,800)
Purchases of treasury stock (84,304) (85,063)
Payments on other long-term debt (75,000) (3,750)
Capital stock surrendered to pay taxes on stock-based compensation (21,022) (5,716)
Proceeds from exercise of stock options 20,209 10,398
Dividends paid (9,016) (8,396)
Debt issuance costs (968)  
Change in cash overdrafts payable (711) (1,090)
Other (uses)/sources (663) 307
Net cash used by financing activities (94,275) (73,310)
Increase/(Decrease) in Cash and Cash Equivalents 1,547 (1,557)
Cash and cash equivalents at beginning of year 11,121 15,310
Cash and cash equivalents at end of period $ 12,668 $ 13,753